Drug Data

Ozempic® Drug Total Revenue (Diabetes : GLP-1) - Global - Novo Nordisk

(in million Danish Krone)

Description

Novo Nordisk Company is a global biopharmaceutical company.

  • Last Updated Date : 27 Jul 2025
  • Study Period : 2018-2024
  • Category : Drug Data
  • Sources : Novo Nordisk (ANNUAL REPORT FORM 10-K)
  • Competitors : Eli Lilly and Company
Rybelsus® Drug Total Revenue (Diabetes : GLP-1) - Global - Novo Nordisk

(in million Danish Krone)

Description

Novo Nordisk Company is a global biopharmaceutical company.

  • Last Updated Date : 27 Jul 2025
  • Study Period : 2018-2024
  • Category : Drug Data
  • Sources : Novo Nordisk (ANNUAL REPORT FORM 10-K)
  • Competitors : Eli Lilly and Company
Victoza® Drug Total Revenue (Diabetes : GLP-1) - Global - Novo Nordisk

(in million Danish Krone)

Description

Novo Nordisk Company is a global biopharmaceutical company.

  • Last Updated Date : 27 Jul 2025
  • Study Period : 2018-2024
  • Category : Drug Data
  • Sources : Novo Nordisk (ANNUAL REPORT FORM 10-K)
  • Competitors : Eli Lilly and Company
Mounjaro® Drug Total Revenue (Diabetes : GIP/GLP-1) - Global - Eli Lilly and Company

(in million U.S. dollars)

Description

Eli Lilly and Company is a global biopharmaceutical company.

  • Last Updated Date : 27 Jul 2025
  • Study Period : 2018-2024
  • Category : Drug Data
  • Sources : Eli Lilly and Company (ANNUAL REPORT FORM 10-K)
  • Competitors : Novo Nordisk
Trulicity® Drug Total Revenue (Diabetes : GIP/GLP-1) - Global - Eli Lilly and Company

(in million U.S. dollars)

Description

Eli Lilly and Company is a global biopharmaceutical company.

  • Last Updated Date : 27 Jul 2025
  • Study Period : 2018-2024
  • Category : Drug Data
  • Sources : Eli Lilly and Company (ANNUAL REPORT FORM 10-K)
  • Competitors : Novo Nordisk

Have questions about how our healthcare intelligence solutions can empower your organization?

up